Drug Information

Drug General Information
Drug ID
D0JI1S
Former ID
DIB001287
Drug Name
RDEA-640
Synonyms
RDEA-800; RDEA-900; VRX-480773; VRX-840773; NNRTIs (HIV infection), Ardea; NNRTIs (HIV infection), Valeant; Non-nucleoside reverse transcriptase inhibitors (HIV infection); Non-nucleoside reverse transcriptase inhibitor 800 series (HIV infection), Ardea; Non-nucleoside reverse transcriptase inhibitor 900 series (HIV infection), Ardea; Non-nucleoside reverse transcriptase inhibitors (HIV infection), Ardea; Non-nucleoside reverse transcriptase inhibitors (HIV infection), Valeant
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Terminated [548289]
Company
Valeant Pharmaceuticals International Inc
Canonical SMILES
O=S(=O)(c1cc(c(NC(=O)CSc2n(c(Br)nn2)c2ccc(C3CC3)c3c2ccc<br />c3)cc1)Cl)N
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Inhibitor [550132]
References
Ref 548289Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024208)
Ref 550132WO patent application no. 2008,0165,22, Novel hiv reverse transcriptase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.